Loading clinical trials...
Loading clinical trials...
The aim of the present study is to determine if there is a change in quality and quantity of sleep perceived by adults and children with GSD and their parents while starting a modified UCCS (Glycosade...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
John Mitchell
NCT06843330 · Glycogen Storage Disease Type Ia
NCT06616545 · Glycogen Storage Disease Type III
NCT03970278 · Glycogen Storage Disease Type IA, Von Gierke's Disease (GSD Type Ia)
NCT04708015 · Glycogen Storage Disease Type IA
NCT04990388 · Glycogen Storage Disease Type III
Montreal Children's hospital
Montreal, Quebec
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions